{
    "code": "60001015",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60001015",
    "time": "2021-06-18 05:20:35",
    "許可證字號": "衛部菌疫輸字第001015號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/06\/20",
    "發證日期": "105\/06\/20",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA06000101500",
    "中文品名": "舒肺樂凍晶注射劑",
    "英文品名": "Nucala Powder for Solution for Injection",
    "適應症": "1.\t嚴重氣喘之維持治療\r\n表現型為嗜伊紅性白血球的嚴重氣喘且控制不良(severe refractory eosinophilic asthma)之6歲以上病人之附加維持治療。\r\n2.\t嗜伊紅性肉芽腫併多發性血管炎：\r\n治療嗜伊紅性肉芽腫併多發性血管炎[eosinophilic granulomatosis with polyangiitis (EGPA)]之成人病人。",
    "劑型": "243凍晶注射劑",
    "包裝": "100毫克玻璃小瓶裝 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "110\/06\/20",
    "主成分略述": "Mepolizumab",
    "限制項目": "02輸　入 5F免除銜接性試驗",
    "申請商名稱": "6201011338  荷商葛蘭素史克藥廠股份有限公司台灣分公司",
    "申請商地址": "臺北市中正區忠孝西路一段66號23、24樓",
    "主製造廠": [
        {
            "製造廠名稱": "FIT0339000  GLAXOSMITHKLINE MANUFACTURING S.P.A.",
            "製造廠廠址": "STRADA PROVINCIALE ASOLANA 90 43056 SAN POLO DI TORRILE PARMA, ITALY",
            "製造廠公司地址": "VIA FLEMING 2 37135 VERONA",
            "製造廠國別": "ITALY",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "1225204000  裕利股份有限公司",
            "製造廠廠址": "桃園市大園區和平里1鄰開和路91號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        },
        {
            "製造廠名稱": "FUS0413100  GLAXOSMITHKLINE LLC",
            "製造廠廠址": "893 RIVER ROAD, CONSHOHOCKEN, PA 19428, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "主成分(drug substance)製造廠"
        }
    ],
    "CCC號列": "30021500005 免疫產品，具有劑量或零售包裝式樣者Immunological products, put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200040100",
            "成分名稱": "Mepolizumab",
            "含量描述": "",
            "含量": "144.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Nucala_vial-106-12-11(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001015&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "020010150001-109-01-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001015&Seq=004&Type=9"
        },
        {
            "title": "02001015 Nucala 標籤-109-07-15(廠商自行上傳)-109-07-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001015&Seq=004&Type=8"
        },
        {
            "title": "02001015 Nucala 外盒標籤-107-06-05(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001015&Seq=003&Type=8"
        }
    ]
}